Information on genetic testing.

The aim of the Competence Centre for Cancer Research is to improve the quality of cancer therapy by developing and implementing new diagnostic platforms and offering the pharmaceutical industry new cancer drug candidates. Currently the project portfolio of CCCR involves 7 projects in drug development and 3 in diagnostics.

CCCR was founded in 2005 by a consortium of eight partners:

Tallinn University of Technology
North Estonia Medical Centre
Trial Form Support TFS AB
CeMines Estonia Ltd
Cambrex Tallinn Ltd
Kevelt Ltd
Celecure Ltd
Inbio Ltd

Other organisations such as University of Tartu , Protobios Ltd. , EPhaG Ltd., Quattromed HTI Laborid Ltd. and Baltic Technology Development are also involved in the work of CCCR as partners.

CCCR is financed by the founding partners and EU Structural Funds in the framework of the Competence Centres’ Programme, which belongs to the international COMPERA network.

In 2007 CCCR was awarded the prize for the best spin-off company by the city of Tallinn.

A brochure about CCCR can be downloaded from here.

CCCR collaborates with Roche